U.S. market Closed. Opens in 10 hours 1 minute

AXDX | Accelerate Diagnostics, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.8000 - 1.9300
52 Week Range 0.7300 - 6.20
Beta 0.23
Implied Volatility 661.51%
IV Rank 31.14%
Day's Volume 71,971
Average Volume 66,379
Shares Outstanding 23,679,400
Market Cap 44,280,478
Sector Healthcare
Industry Medical - Devices
IPO Date 1994-04-07
Valuation
Profitability
Growth
Health
P/E Ratio -1.39
Forward P/E Ratio N/A
EPS -1.35
1YR Price Target 5.00
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 134
Country USA
Website AXDX
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques.
AXDX's peers: CVRX, NPCE, ANIK, AXGN, AORT, SGHT, OFIX, AVNS, CNMD, KIDS, SRDX, ITGR, OSA, LIVN, ELMD, LUNG, IRMD, TCMD, VERO
*Chart delayed
Analyzing fundamentals for AXDX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is on medium level and Health is frighteningly weak. For more detailed analysis please see AXDX Fundamentals page.

Watching at AXDX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on AXDX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙